Bob covers the money in health care, focusing on health insurance and hospitals. His stories delve into Medicare Advantage, opaque prescription drug benefits, and how much executives actually make. He ...
As part of broad drug pricing deals with the Trump administration, more than two dozen pharma companies agreed to sell drugs to state Medicaid programs at prices available in peer countries under ...
Several Texas hospitals are suing an out-of-state Blue Cross for unpaid medical claims, highlighting the varying standards for whether care is medically necessary.
We’re very actively hiring,” Karim Mikhail, director of FDA’s Center for Biologics Evaluation and Research, told drug ...
Health secretary Kennedy announced a new effort to improve autism diagnoses, arguing that the current model is outdated ...
Kennedy Jr. named eight new members to the U.S. Preventive Services Task Force, an influential panel of experts who assess ...
The FDA approved a new gene therapy for Sanfilippo syndrome type A, an ultra-rare disease sometimes known as childhood ...
A breast cancer drug from AstraZeneca will now be available in England after a pricing deal was reached, in part a result of ...
Over the past 25 years, there’s been a dramatic change in how we understand children who don’t “listen,” writes behavioral ...
The GOP bill directs MedPAC to study the topic of overpayments to Medicare Advantage plans in a manner that’s more favorable ...
For all the talk of a hiring spree at the FDA after DOGE cuts last year, the reality is more complicated and filled with ...
Cautious optimism in the Ebola outbreak, FDA still stymied by DOGE cuts, and other health updates from the Morning Rounds ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results